Johnson & Johnson Covid vaccine approved for use in Switzerland
Johnson & Johnson's Covid-19 vaccine is the third shot to be approved by Switzerland with vaccines from Pfizer and
BioNTech and from Moderna.
Keystone
Health regulator Swissmedic has given the green light for the use of the vaccine produced by Johnson & Johnson (J&J). This is the third vaccine to be approved in Switzerland. However, Switzerland has not yet ordered any doses of J&J's one-shot vaccine.
“Swissmedic has temporarily authorised the ‘Covid-19 vaccine Janssen’ developed by the pharmaceutical corporation Johnson & Johnson for people aged 18 and over,” Swissmedic said in a statementExternal link on Monday.
To date Switzerland has not ordered J&J’s one-shot vaccine, which was approved in the United States, Canada and the European Union. While deliveries have begun in the US, Europe is not set to get the vaccine until the second quarter of 2021. The Swiss Federal Office of Public Health does not expect it to be available until autumnExternal link.
More
More
Covid-19: vaccine rollout starts to bear fruit among Swiss seniors
This content was published on
Switzerland’s coronavirus vaccination campaign is starting to show its first effects, data shows.
Swissmedic said the submitted study data showed an average efficacy of 66.9% in the investigated age groups.
“Severe and critical forms of Covid-19 can be prevented with this vaccine (in almost 85% of cases),” said Swissmedic. “A positive effect was also demonstrated against the dominant mutations in Brazil and South Africa (SARS-CoV-2 variants).”
The advantage of the Johnson & Johnson vaccine is that it only needs to be administered as a single dose. It is also relatively easy to store and transport. The vaccine can be stored frozen at -25 °C to -15 °C and can be transported either deep-frozen or after thawing at between 2 °C and 8 °C. Once removed from the freezer, the unopened vaccine can be stored in the refrigerator for up to three months.
“It is based on a human adenovirus (cold virus) containing the blueprint for the spike proteins of the coronavirus SARS-CoV-2, which in turn forms the basis for triggering the desired immune response to the virus in the human immune cells,” said Swissmedic.
What’s been ordered?
However, Switzerland decided not to order the J&J vaccine amid its first round of vaccine purchases, on grounds that it would likely not get the vaccine amid supply bottlenecks until autumn 2021.
For the population of 8.6 million people, the Swiss government has ordered nearly 36 million vaccine doses from five companies: Pfizer/BioNTech, Moderna, AstraZeneca, Curevac and Novavax. So far, Swissmedic has given the green light to two Covid-19 vaccines: from Pfizer/BioNTech and Moderna. The application from AstraZeneca is still under review.
Vaccinations began in late December in the Alpine nation. Switzerland has set an ambitious target: to inoculate six million people (70% of the population) on a voluntary basis by summer with up to 70,000 vaccine shots per day. While the cantons have set up the necessary infrastructure to vaccinate the population, the authorities admit that progress has been “insufficient” largely due to production bottlenecks.
A survey conducted on behalf of the Swiss Broadcasting Corporation in January found that 41% of people surveyed said they would be willing to get vaccinated immediately.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Pilots’ union seeks to end deal with SWISS over working conditions
This content was published on
The Aeropers pilots’ union is expected to end its collective labour agreement with SWISS, as it pushes for better working conditions for its members.
Drugs often approved for wider use than tested, says Swiss study
This content was published on
A study by the University of Zurich, ETH Zurich and Yale and Harvard universities found that many medicines are approved for groups not tested in trials.
This content was published on
Over the four days, around 98,000 people – including volunteers – made their way up Bern’s local mountain for the 42nd edition of the festival.
Foreign residents in Moutier gain voting rights before town joins canton Jura
This content was published on
Foreign nationals living in Moutier will be able to vote in local and cantonal elections this year, even before the town joins the canton of Jura in 2026.
This content was published on
By 8am on Saturday, an 11-kilometre queue had formed at the Gotthard tunnel’s northern entrance, with drivers facing nearly two hours of delays.
Plant-based meat market in Switzerland set to grow to CHF361 million by 2030
This content was published on
Switzerland’s market for plant-based meat alternatives has a potential value of around CHF 242 million this year, though it remains a niche market.
This content was published on
The army is looking for a modern solution for its decommissioned fortress mortar bunkers, with plans to turn them into hardened defence hubs.
This content was published on
Spain ended Switzerland’s run in the Women’s Euros on Friday, but fans in Bern made history with the largest supporters’ march in Women’s Euros history.
This content was published on
Solar energy pioneer Raphaël Domjan and his team continued preparations for the altitude record attempt at 10,000 metres with the SolarStratos solar aircraft.
This content was published on
Cattle in the canton of Geneva and in the neighbouring region of Terre Sainte in the canton of Vaud are being vaccinated against the contagious viral skin nodule disease. The first cases of the animal disease were reported at the end of June in France, just outside Geneva.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Data on AstraZeneca vaccine insufficient for Swiss approval
This content was published on
Swissmedic says it has not yet received enough robust data from clinical trials to give the green light to the Covid-19 vaccine.
This content was published on
Media reports indicate that vaccinating everyone who wants to by summer relies on meeting ambitious vaccine delivery targets in spring.
Covid-19 vaccine: Why we still have a long wait ahead
This content was published on
Countries have started rolling out a Covid-19 vaccine, but it will likely take years to manufacture doses at the scale needed to reach the masses.
Swiss regulator warns of fake Covid-19 vaccines online
This content was published on
Scammers are selling dangerous fake coronavirus vaccines on the internet, Switzerland’s health regulator Swissmedic warned on Tuesday.
Swiss factory rushes to prepare for Moderna Covid-19 vaccine
This content was published on
Workers are racing to set up production lines at the Lonza factory in Visp to be able to start making a vaccine for US firm Moderna later this year.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.